Company profile
healiva®
Advanced Cell Therapy and Regenerative Medicine
- Industry
- Biotechnology
- Employees
- 4
- Headquarters
- Lugano, Canton Ticino
- Founded
- 2020
- LinkedIn followers
- 1,349
- Office locations
- 1
healiva® company summary
healiva® is a company in the Biotechnology industry, headquartered in Lugano, Canton Ticino, founded in 2020. On LinkedIn the company has around 4 employees and 1,349 followers.
What technology does healiva® use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About healiva®
Healiva`s mission is to heal life, by offering a portfolio of innovative acute and chronic wound care solutions, which are personalized and affordable. Our approach combines enzyme technology, cell therapies and medical devices. We offer end-to-end offering of wound care solutions. Our multi-pronged approach to become the go-to-provider for all wound care needs – from wound debridement to treatment of severe wounds. 2-3% of the elderly suffer from painful venous/arterial leg ulcers and nearly 25% of diabetics may develop diabetic foot ulcers in their lifetimes. This figure set to rise with the increasing prevalence of contributing factors, including diabetes, advanced age, and obesity. This burden is also borne by healthcare systems, which spend 2% of their budgets on wound management. About ≈60% of chronic wounds remain unhealed. There remains a major gap in the current treatment paradigm. No permanent therapy for non-healing wounds currently exists. A successful regimen can prevent osteomyelitis, hospitalisation, amputation, and even death, allowing patients to re-establish their normal work/life routines. Healiva is targeting key pain-points in the patient care pathway. Our multifaceted customer base encompasses hospitals, medical practitioners, insurance providers and patients. We are developing a unique selling proposition for chronic wounds healing targeting the high cost of care, time to heal, requirements for frequent dressing changes and specialist medical expertise, whilst reducing wounds reoccurrence and accelerating patients’ re-establishment of normal work/life routines. Healiva’s portfolio potentially address the growing un-met need for chronic wound care, which forms part of the global €15.6B wound care market.
Where is healiva® located?
healiva® lists 1 location.
Compare companies similar to healiva®
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
healiva® healiva.com | Biotechnology | 4 | 2020 | Lugano, Canton Ticino |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about healiva®
What does healiva® do?
Healiva`s mission is to heal life, by offering a portfolio of innovative acute and chronic wound care solutions, which are personalized and affordable. Our approach combines enzyme technology, cell therapies and medical devices. We offer end-to-end offering of wound care solutions. Our multi-pronged approach to become the go-to-provider for all wound care needs – from wound debridement to treatment of severe wounds. 2-3% of the elderly suffer from painful venous/arterial leg ulcers and nearly 25% of diabetics may develop diabetic foot ulcers in their lifetimes. This figure set to rise with the increasing prevalence of contributing factors, including diabetes, advanced age, and obesity. This burden is also borne by healthcare systems, which spend 2% of their budgets on wound management. About ≈60% of chronic wounds remain unhealed. There remains a major gap in the current treatment paradigm. No permanent therapy for non-healing wounds currently exists. A successful regimen can prevent osteomyelitis, hospitalisation, amputation, and even death, allowing patients to re-establish their normal work/life routines. Healiva is targeting key pain-points in the patient care pathway. Our multifaceted customer base encompasses hospitals, medical practitioners, insurance providers and patients. We are developing a unique selling proposition for chronic wounds healing targeting the high cost of care, time to heal, requirements for frequent dressing changes and specialist medical expertise, whilst reducing wounds reoccurrence and accelerating patients’ re-establishment of normal work/life routines. Healiva’s portfolio potentially address the growing un-met need for chronic wound care, which forms part of the global €15.6B wound care market.
How many employees does healiva® have?
healiva® has around 4 employees on LinkedIn.
Where is healiva® headquartered?
healiva® is headquartered in Lugano, Canton Ticino.
When was healiva® founded?
healiva® was founded in 2020.
Build a lead list from companies like healiva®
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.